FDA Enforcement Class II Terminated

Percept PC Implantable Neurostimulator (INS) - Product Usage: The Percept PC is a neurostimulation device for deep brain stimulation therapy. It is indicated for DBS treatment for Parkinson s disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy.

Recall: Z-0612-2021 · Reported December 23, 2020

Enforcement

Recall Number
Z-0612-2021
Event ID
86907
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Medtronic Neuromodulation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 23, 2020
Initiation Date
November 19, 2020
Classification Date
December 16, 2020
Termination Date
April 3, 2023
Address
7000 Central Ave Ne, N/A, Minneapolis, MN, 55432-3568, United States

Description

Percept PC Implantable Neurostimulator (INS) - Product Usage: The Percept PC is a neurostimulation device for deep brain stimulation therapy. It is indicated for DBS treatment for Parkinson s disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy.

Reason

A software anomaly in the A620 Patient Programmer application was identified that results in failure to connect with the Percept PC device.

Code Info

Model Number: B35200; GTIN: 00763000253363; Serial Numbers: NPI706941H, NPI707024H, NPI707000H, NPI706992H, NPI706963H, NPI706962H, NPI706987H, NPI706945H, NPI706952H, NPI706954H, NPI706955H, NPI706957H

Distribution

US Nationwide distribution including in the states of Arizona, California, New Hampshire, Pennsylvania, Tennessee, Texas, Washington.

Quantity

12 devices